http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114767842-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b5bbe3f04530ef25f43228ccb215138
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
filingDate 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1955c97d5c8a03d8059975cec239a080
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b7c4461ff6e46e5217a7d0bc7d9963c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_225711464ad28c5b747bc585428c81de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ef3f948fab83ac197b4f33790b8cbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c988aeeb066d7559910ebbb84226b43c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e661697b73adb34704d6477827fe607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587519e4a83e6afb315d0dcaa3923e7b
publicationDate 2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114767842-A
titleOfInvention A kind of freeze-dried preparation of recombinant BCG and its preparation method and use
abstract The invention provides a freeze-dried preparation of recombinant BCG vaccine, which contains the following components in parts by weight: 0.05 part of recombinant BCG, 1-3 parts of dextran-40, 2.5-3.5 parts of sucrose, sodium glutamate 0.2-0.5 part, potassium chloride 0.2-0.7 part, trehalose 3-4 part, Tween-80 0.005-0.015 part. The freeze-dried preparation of the recombinant BCG vaccine provided by the invention has high quantity of viable bacteria, stable properties and easy storage, and has good application value as a vaccine for preventing tuberculosis.
priorityDate 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71315856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428402457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23677676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450648135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10925912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453569306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426484532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526338

Total number of triples: 45.